Jacobson Pharma Corporation Limited (HKG:2633)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.270
0.00 (0.00%)
At close: Feb 13, 2026

HKG:2633 Income Statement

Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
1,5331,5771,4681,2681,5961,446
Revenue Growth (YoY)
-1.88%7.43%15.79%-20.55%10.35%-7.99%
Cost of Revenue
854.18883.96847.32728.68975.02884.83
Gross Profit
679.27692.94620.48538.92620.52561.08
Selling, General & Admin
327.97324.24332.38297.92397.63407.59
Other Operating Expenses
-62.98-64.17-23.31-28.27-25.58-10.83
Operating Expenses
264.99260.07309.07269.65372.06396.76
Operating Income
414.28432.87311.4269.27248.47164.33
Interest Expense
-33.76-41.37-78.71-61.41-25.69-30.14
Interest & Investment Income
12.3216.6927.6817.883.022.09
Earnings From Equity Investments
3.330.40.17-1.63-3.77-5.53
Currency Exchange Gain (Loss)
-0.520.3-0.10.360.05-1.58
EBT Excluding Unusual Items
395.65408.89260.44224.47222.08129.17
Gain (Loss) on Sale of Investments
0.11-0.841.62-3.37.46
Gain (Loss) on Sale of Assets
-1.75-4.1-0.05-3.420.251.07
Asset Writedown
-22.22-30.32-7.43-5.550.49
Other Unusual Items
---29.30.2582.39
Pretax Income
371.78373.63254.58250.35231.43220.57
Income Tax Expense
69.2172.7944.4142.9843.7334.26
Earnings From Continuing Operations
302.58300.83210.17207.37187.71186.31
Earnings From Discontinued Operations
--80.6175.84-0
Net Income to Company
302.58300.83290.78283.21187.71186.31
Minority Interest in Earnings
---23.81-32.17-10.04-12.6
Net Income
302.58300.83266.97251.04177.67173.71
Net Income to Common
302.58300.83266.97251.04177.67173.71
Net Income Growth
19.49%12.68%6.34%41.30%2.28%-19.44%
Shares Outstanding (Basic)
1,9921,9861,9201,9111,9161,916
Shares Outstanding (Diluted)
1,9921,9861,9201,9121,9161,916
Shares Change (YoY)
1.80%3.42%0.45%-0.21%-0.03%-3.37%
EPS (Basic)
0.150.150.140.130.090.09
EPS (Diluted)
0.150.150.140.130.090.09
EPS Growth
17.41%8.96%5.89%41.57%2.30%-16.63%
Free Cash Flow
235.19278.39354.85567.09343.08345.9
Free Cash Flow Per Share
0.120.140.180.300.180.18
Dividend Per Share
0.0980.0900.0550.0520.0390.023
Dividend Growth
50.00%63.64%6.18%33.51%68.70%-48.89%
Gross Margin
44.30%43.94%42.27%42.52%38.89%38.80%
Operating Margin
27.02%27.45%21.22%21.24%15.57%11.37%
Profit Margin
19.73%19.08%18.19%19.80%11.13%12.01%
Free Cash Flow Margin
15.34%17.66%24.18%44.74%21.50%23.92%
EBITDA
530.84541.86415.94380.38391.76299.89
EBITDA Margin
34.62%34.36%28.34%30.01%24.55%20.74%
D&A For EBITDA
116.56108.99104.53111.12143.29135.57
EBIT
414.28432.87311.4269.27248.47164.33
EBIT Margin
27.02%27.45%21.22%21.24%15.57%11.37%
Effective Tax Rate
18.62%19.48%17.45%17.17%18.89%15.53%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.